Deficient MGMT and proficient hMLH1 expression renders gallbladder carcinoma cells sensitive to alkylating agents through G2-M cell cycle arrest.

International journal of oncology

Volumn 26, Issue 6, 2005, Pages 1653-1661

  Sato, Ken ^a   Kitajima, Yoshihiko ^a   Kohya, Naohiko ^a   Miyoshi, Atsushi ^a   Koga, Yasuo ^a   Miyazaki, Kohji ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; CARRIER PROTEIN; DACARBAZINE; MESSENGER RNA; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; METHYLNITROSOUREA; MLH1 PROTEIN, HUMAN; MLH1 PROTEIN, MOUSE; NUCLEAR PROTEIN; TUMOR PROTEIN;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CELL CYCLE G2 PHASE; CELL DIVISION; CHEMISTRY; DRUG EFFECT; EXPERIMENTAL NEOPLASM; FEMALE; FLOW CYTOMETRY; GALLBLADDER TUMOR; GENETICS; HUMAN; MOUSE; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; CARRIER PROTEINS; CELL DIVISION; CELL LINE, TUMOR; DACARBAZINE; FEMALE; FLOW CYTOMETRY; G2 PHASE; GALLBLADDER NEOPLASMS; HUMANS; METHYLNITROSOUREA; MICE; MICE, INBRED BALB C; NEOPLASM PROTEINS; NEOPLASMS, EXPERIMENTAL; NUCLEAR PROTEINS; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; RNA, MESSENGER;

EID: 22344454578     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.26.6.1653     Document Type: Article

References (0)